Thalidomide
1 Inquiries
50-35-1
2026-08-12
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName Thalidomide Cat No CEI-0903 Description Thalidomide was introduced as a sedative drug,immunomodulatory agent and also is investigated for treating symptoms of many cancers. Thalidomide inhibits an E3 ubiquitin ligase, which is a CRBN-DDB1-Cul4A complex. Alias Thalomid CAS No 50-35-1 Molecular Weight 258.23 Storage 2 years -20 centigrade Powder; 2 weeks 4 centigrade in DMSO; 6 months -80 centigrade in DMSO. Synonyms Thalomid Targets E3A Molecular Formula C13H10N2O4 Solubility DMSO 52 mg/mL; Water <1 mg/mL; Ethanol 2 mg/mL category Synthetic Anti-infective Drugs(c1421) cas_num 50-35-1 Basic Info-
Product Name:
Thalidomide
Other Name:1H-Isoindole-1,3(2H)-dione,2-(2,6-dioxo-3-piperidinyl)-;Phthalimide,N-(2,6-dioxo-3-piperidyl)-;2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;K 17;Contergan;N-(2,6-Dioxo-3-piperidyl)phthalimide;Distaval;Kevadon;α-Phthalimidoglutarimide;α-(N-Phthalimido)glutarimide;3-Phthalimidoglutarimide;N-Phthaloylglutamimide;α-N-Phthalylglutaramide;Softenon;Thalidomide;Sedoval;Softenil;Quetimid;Talimol;(±)-Thalidomide;1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline;Thalomid;Celgene;Suaramide;Talinol;Neurosedyn;NSC 66847;Sedalis;Pantosediv;NSC 527179;Myrin;Sauramide;Pharmion;Thaled;Synovir;N-(2,6-Dioxo-3-piperidinyl)phthalimide;Immunoprin;2-(2,6-Dioxopiperidin-3-yl)isoindoline-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)isoindole-1,3-dione;2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione;731-40-8;14088-68-7
CAS No.:50-35-1
Molecular Formula:C13H10N2O4
InChIKeys:InChIKey=UEJJHQNACJXSKW-UHFFFAOYSA-N
Molecular Weight:258.23
Exact Mass:258.23
EC Number:200-031-1
HScode:2925190090
Categories:
Characteristics-
PSA:
83.6
XLogP3:0.3
Appearance:white
Density:1.5±0.1 g/cm3
Melting Point:270 °C
Boiling Point:509.7°C at 760 mmHg
Flash Point:262.1±28.2 °C
Refractive Index:1.646
Water Solubility:H2O: <0.1 g/100 mL at 22 ºC;45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.6 mg/mL
Storage Conditions:Store at RT
Vapor Pressure:2.05X10-14 mm Hg at 25 deg C (est)
Toxicity:LD50 oral in mouse: 2gm/kg
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Reproductive toxicity, Category 1A
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Vietnam
Thalidomide
25.00 KG Jul 14, 2023 Post an enquiry for this product